Select your location:

Location

Select your language:

KUKA receives Global Company of the Year Award 2020 for its Medical Robotics division

Unique, progressive, valuable: The consulting company Frost & Sullivan analyzed the medical robotics market, and in doing so recognises KUKA's LBR Med as one of the most advanced robots in the industry. For the robot and its innovative achievements in the field of medical robotics as a whole, KUKA has received the "Company of the Year" award from Frost & Sullivan.

12 March, 2020

Every year, the globally active consulting firm presents the award to a company that is a leader in its industry, particularly in innovation and growth. KUKA convinced Frost & Sullivan on these points. The Augsburg-based company accepted the award for the Medical Robotics division at a gala in London on 11 March. Frost & Sullivan considered KUKA's complete product portfolio in the field of medical robotics when making its decision. This evaluation ranges from large robots for high payloads, which are used for example, to carry heavy radiation cannons for tumor treatment, to sensitive small robotics.


Axel Weber (right) received the "Company of the Year Award" in London.

The collaborative robot for medicine: The LBR Med from KUKA - uniquely configurable and versatile

The LBR Med, which launched on the market around two years ago, was a key factor here. The medical robot is the first robot certified for integration into a medical device. It is specially adapted to medical requirements and is used in very different applications such as diagnosis, rehabilitation, aesthetic surgery, or medical treatment in the operating room. Due to the spectrum of possible applications in the demanding field of medical technology, Frost & Sullivan considers the LBR Med to be one of the most advanced robots on the market.

I am very pleased with this award. In the future, we will continue to contribute to the advancement of robotics in medicine, not only to support physicians in their work, but also to enable patients to receive the best possible diagnosis and treatment.

Axel Weber, Vice President Medical Robotics